Comparison of the performance of the 10 CV (10 fold cross validation) model and the permutated model. by Sakuni Rankothgedera (11457923)

Principal component analyses indicates no significant separation based on the type of brain regions. by Marcell Miski (11965487)

Time-based changes in factor scores by group. by Shota Fujiwara (22410782)

Subjects:

Mean and SDs of the significant regions. by Faran Sabeti (6166766)

Subjects:

Gene specific primers used for <i>GmNN1/FT2a</i> fine mapping. by Xinxin Li (281237)

Intensity comparation of significantly changed metabolites of four groups of control, model, YYD and RER groups. by Guanwen Gong (9693076)

<i>In vivo</i> voxel based morphometry identified areas of significant enlargement in trained animals relative to the controls. by Alexandra Badea (352052)

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

Subjects:

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

Significance analysis results. by Yicheng Long (366418)

“…By incorporating the dynamics of user behavioral changes and the logic of platform scaling driven by investment, two representative cybersecurity datasets are selected for analysis: the Canadian Institute for Cybersecurity Intrusion Detection System 2017 and the Network-Based Intrusion Detection Evaluation Dataset 2015. …”

K-fold cross validation accuracy of different models. by Shayla Naznin (13014015)

Subjects:

Quantitative Venn diagram of proteins expressed in sera of patients with clinically significant portal hypertension (CSPH) and non-CSPH group. by Frane Pastrovic (18349349)

Nucleotide changes per sample per base. by Anthony Nearman (12693218)

Changes in farmland abandonment based on SSPs Scenarios. by Yuling Jin (11872953)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…Spearman correlations between the predicted and observed activity of the key BO-NN features were calculated and averaged over the six cross-validation folds. …”

Differential treatment effects and clinically significant change in depression (IDS) for all three treatments over time. by Brendan Cullen (7003883)

Changes made to the scale based on the cognitive interviews. by Sarah Yeo (15428735)

phospho-PMK-1 levels are not significantly changed under ADR. by Lucas Mergan (16455805)

Comparison between the air temperature calculated values obtained by ten-fold cross validation method and observed values. by Wang Runke (13256851)

Significant genes identified in the gene-based test with GWAS summary data. by Samantha Gonzales (8798435)